1-3 of 3
Renata Farioli
Close
Sort by
Journal Articles

Purging "In Vivo" with Alemtuzumab (Campath-1H) before Autologous Stem Cell Transplantation (ASCT) in Chronic Lymphocytic Leukemia (CLL).

Marco Montillo, Alessandra Tedeschi, Roberto Cairoli, Sara Miqueleiz, Barbara Scarpati, Anna Maria Cafro, Liliana Intropido, Renata Farioli, Silvio Veronese, Enrica Morra
Journal: Blood
Blood (2005) 106 (11): 2927.
https://doi.org/10.1182/blood.V106.11.2927.2927
Published: 2005
Journal Articles

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Ester Pungolino, MD, Michela Draisci, MD, Livio Gargantini, MD, Renata Farioli, PhD, Valentina Rossi, MD, Paola Cozzi, MD, Sara Miqueleiz Alamos, MD, Anna Maria Cafro, MD, Enrica Morra, MD
Journal: Blood
Blood (2004) 104 (11): 4690.
https://doi.org/10.1182/blood.V104.11.4690.4690
Published: 2004
Journal Articles

Alemtuzumab as Consolidation after a Response to Fludarabine Is Effective To Purge Residual Disease in Patients with Chronic Lymphocytic Leukemia.

Marco Montillo, MD, Alessandra Tedeschi, MD, Valentina Rossi, MD, Anna Maria Cafro, MD, Roberto Cairoli, MD, Silvio Veronese, PhD, Barbara Scarpati, PhD, Renata Farioli, PhD, Mario Regazzi, MD, Marcello Gambacorta, MD, Enrica Morra, MD
Journal: Blood
Blood (2004) 104 (11): 479.
https://doi.org/10.1182/blood.V104.11.479.479
Published: 2004